Understanding Financial Toxicity Among Patients With RCC

Cristiane D. Bergerot, PhD, discusses how financial toxicity associated with renal cell carcinoma is impacting oncologists and their patients.

Cristiane D. Bergerot, PhD, of the CETTRO Cancer Research Hospital, discusses how financial toxicity associated with renal cell carcinoma is impacting oncologists and their patients.

Transcription:

0:08 | Patients with renal cell carcinoma experience heightened anxiety about increasing financial toxicity related to COVID-19. They're always also concerned that their money in savings or even retirement assets would not cover the cost of their treatments, or that they will lose their job. It also was interesting that a great proportion of patients do not feel like they are in control of their financial situation.